PHARMACOGENETIC MARKERS FOR PREDICTING AN EFFECTIVE RESPONSE TO BISPHOSPHONATES WHEN PLANNING TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS
About the Authors
E. V. Rudenko
Belarusian State Medical University
Belarus
Belarus
Minsk
V. Alekna
Vilnius University
Lithuania
Lithuania
Vilnius
E. V. Rudenko
Belarusian Medical Academy of Postgraduate Education
Belarus
Belarus
Minsk
M. Tamulaitiene
Vilnius University
Lithuania
Lithuania
Vilnius
O. Yu. Samokhovets
Belarusian Medical Academy of Postgraduate Education
Belarus
Belarus
Minsk
E. V. Kobets
Institute of Genetics and Cytology of the National Academy of Sciences of Belarus
Belarus
Belarus
Minsk
P. M. Morozik
Institute of Genetics and Cytology of the National Academy of Sciences of Belarus
Belarus
Belarus
Minsk
Review
For citations:
Rudenko E.V., Alekna V., Rudenko E.V., Tamulaitiene M., Samokhovets O.Yu., Kobets E.V., Morozik P.M. PHARMACOGENETIC MARKERS FOR PREDICTING AN EFFECTIVE RESPONSE TO BISPHOSPHONATES WHEN PLANNING TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS. Osteoporosis and Bone Diseases. 2020;23(2):147-148. (In Russ.)
Views:
231
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
